cmpd semaglutide for Weight Loss pc semaglutide cmpd Compounded Semaglutide

Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas

Jan 20, 2026 9 min read READ MORE Fitness GLP-1 and Strength Training: The Key to Lasting Weight Loss Using a GLP-1 medication

This lowers blood glucose levels, increases satiety, and reduces food intake

Our trusted and reliable clinicians offer essential weight loss support, from providing diet plans (including those suitable for vegans) to offering guidance on travelling with your medication

Others may benefit from tirzepatides dual-action mechanism

Households with higher levels of income experience an even larger decline in spending by nearly 9% or $690 less annually